{"id":769857,"date":"2026-05-03T06:30:24","date_gmt":"2026-05-03T06:30:24","guid":{"rendered":"https:\/\/www.europesays.com\/us\/769857\/"},"modified":"2026-05-03T06:30:24","modified_gmt":"2026-05-03T06:30:24","slug":"scientists-develop-bioengineered-chewing-gum-that-could-help-fight-oral-cancer","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/769857\/","title":{"rendered":"Scientists Develop Bioengineered Chewing Gum That Could Help Fight Oral Cancer"},"content":{"rendered":"<p><a href=\"https:\/\/scitechdaily.com\/images\/Woman-Chewing-Gum.jpg\" rel=\"nofollow noopener\" target=\"_blank\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-290137 size-large\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2026\/05\/Woman-Chewing-Gum-777x518.jpg\" alt=\"Woman Chewing Gum\" width=\"777\" height=\"518\"  \/><\/a>Scientists have developed a bioengineered chewing gum that dramatically reduces cancer-linked microbes in the mouth, including HPV and harmful bacteria tied to head and neck cancers. Credit: Stock<\/p>\n<p><strong>Bioengineered gum lowers HPV and harmful oral bacteria, offering a promising new approach for cancer prevention and treatment.<\/strong><\/p>\n<p>Researchers led by Henry Daniell of the School of Dental Medicine at the <a href=\"https:\/\/scitechdaily.com\/tag\/university-of-pennsylvania\/\" rel=\"nofollow noopener\" target=\"_blank\">University of Pennsylvania<\/a><br \/>report that extracts from a bioengineered chewing gum can significantly lower levels of three microbes associated with head and neck squamous cell cancer (HNSCC). The results, published in Scientific Reports, point to a potential low-cost and accessible treatment approach.<\/p>\n<p>HNSCC is a widespread cancer that forms in the tissues lining the mouth and throat. It is often aggressive and linked to poor outcomes, particularly when detected late, Daniell explains. He adds that many recently approved cancer drugs have done little to improve quality of life or five-year survival, highlighting the need for new treatment strategies.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-518353\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2026\/05\/Bioengineered-Bean-Gum-From-the-Lab-of-Penn-Dentals-Henry-Daniell-777x518.jpg\" alt=\"Bioengineered Bean Gum From the Lab of Penn Dental\u2019s Henry Daniell\" width=\"777\" height=\"518\"  \/>A bioengineered bean gum from the lab of Penn Dental\u2019s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth. Credit: Kevin Monko\/Penn Dental Medicine<\/p>\n<p>The team built on earlier research involving chewing gum made from lablab beans (bean gum) that contains FRIL, a protein with natural antiviral properties. They analyzed oral samples from patients with HNSCC to measure levels of three cancer-associated microbes: human papilloma virus, or HPV, along with two types of bacteria, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn).<\/p>\n<p>Gum Therapy Cuts HPV and Harmful Oral Bacteria<\/p>\n<p>\u201cThe global increase in oropharyngeal cancer is linked to HPV infection,\u201d says Daniell. \u201cAnd Pg and Fn infections worsen survival rates of untreated recurrent or metastatic oral cancer, even after surgery and risk-adjusted adjuvant, or supplemental, therapies.\u201d<\/p>\n<p>Tests showed that extracts from the bean gum reduced HPV levels by 93% in saliva and by 80% in oral rinse samples. After adding protegrin, an antimicrobial peptide that targets harmful bacteria, a single dose brought Pg and Fn levels close to zero while leaving beneficial oral bacteria intact.<\/p>\n<p>This differs from radiation therapy, which reduces helpful bacteria and can increase disease-causing yeast (Candida albicans).<\/p>\n<p>\u201cLip and oral cavity cancer was the seventh leading cancer type in cancer incidence and mortality rate worldwide in adolescents, young adults, and middle-aged adults in 2022,\u201d says Daniell. \u201cOur findings support the value of advancing these therapies to clinical trials as adjuvants with current treatments or as prophylaxis to prevent infection and transmission.\u201d<\/p>\n<p>Reference: \u201cEx vivo HNSCC clinical studies using saliva and antiviral or antibacterial chewing gums reveal reduction in carcinogenic microbes\u201d by Henry Daniell, Geetanjali Wakade, Rahul Singh, Smruti Nair, Saroj K. Basak, Eri S. Srivatsan, Andr\u00e9s M. Bur, Sufi M. Thomas and Marilene B. Wang, 9 February 2026,\u00a0Scientific Reports.<br \/><a href=\"https:\/\/www.nature.com\/articles\/s41598-026-39062-w\" rel=\"nofollow noopener\" target=\"_blank\">DOI: 10.1038\/s41598-026-39062-w<\/a><\/p>\n<p>This work was supported by NIH (grant 5-R01-HL 107904-13 awarded to Henry Daniell), the Academic Senate Grant of the David Geffen School of Medicine at UCLA (the Surgical Education Research Program), and the National Cancer Institute Cancer Center (Support Grant P30 CA168524).<\/p>\n<p><b>Never miss a breakthrough: <a href=\"https:\/\/scitechdaily.com\/newsletter\/\" rel=\"nofollow noopener\" target=\"_blank\">Join the SciTechDaily newsletter.<\/a><\/b><br \/><b>Follow us on <a href=\"https:\/\/www.google.com\/preferences\/source?q=scitechdaily.com\" rel=\"nofollow noopener\" target=\"_blank\">Google<\/a> and <a href=\"https:\/\/news.google.com\/publications\/CAAqLAgKIiZDQklTRmdnTWFoSUtFSE5qYVhSbFkyaGtZV2xzZVM1amIyMG9BQVAB?hl=en-US&amp;gl=US&amp;ceid=US%3Aen\" rel=\"nofollow noopener\" target=\"_blank\">Google News<\/a>.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"Scientists have developed a bioengineered chewing gum that dramatically reduces cancer-linked microbes in the mouth, including HPV and&hellip;\n","protected":false},"author":3,"featured_media":769858,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[235,210,103183,20302,15097,67,132,24003,68],"class_list":{"0":"post-769857","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-cancer","9":"tag-health","10":"tag-hpv","11":"tag-microbiome","12":"tag-oncology","13":"tag-united-states","14":"tag-unitedstates","15":"tag-university-of-pennsylvania","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116509240757341704","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/769857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=769857"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/769857\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/769858"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=769857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=769857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=769857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}